ascopubs.org

Gemcitabine and cisplatin chemotherapy plus penpulimab combined with or without anlotinib as neoadjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: A ...

Differential sensitivities of primary tumor and lymph nodes to induction chemotherapy and definitive radiotherapy in nasopharyngeal carcinoma. Phase 2 study of xevinapant + chemoradiotherapy (CRT) vs ...
Renal & Urology News

Benefit of Adding Immunotherapy to Chemo May Vary According to Platinum Agent Used

Immunotherapy improved overall survival when added to cisplatin-gemcitabine but not when added to carboplatin-gemcitabine. Adding immunotherapy to platinum-gemcitabine chemotherapy can improve ...
ascopubs.org

Real-world effectiveness and safety of enfortumab vedotin plus pembrolizumab versus gemcitabine-platinum chemotherapy in first-line treatment of advanced urothelial carcinoma ...

Outcomes with subsequent therapies post-enfortumab vedotin/pembrolizumab (EVP) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study. This is an ASCO Meeting Abstract ...
Cancer Network

Gemcitabine Intravesical System May Transform Bladder Cancer Treatment

Gary Steinberg, MD, discusses the clinical significance of the new FDA-approved gemcitabine intravesical system for BCG-unresponsive NMIBC. For patients with Bacillus Calmette-Guérin ...